|
ROCK1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.613600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.766600E-01 |
| Normal-vs-Stage2 |
5.243800E-02 |
| Normal-vs-Stage3 |
1.476650E-01 |
| Normal-vs-Stage4 |
7.068400E-01 |
| Stage1-vs-Stage2 |
7.642200E-02 |
| Stage1-vs-Stage3 |
1.681970E-01 |
| Stage1-vs-Stage4 |
8.560600E-01 |
| Stage2-vs-Stage3 |
4.504800E-01 |
| Stage2-vs-Stage4 |
1.719410E-01 |
| Stage3-vs-Stage4 |
4.059000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.555800E-01 |
| Normal-vs-AfricanAmerican |
7.428800E-01 |
| Normal-vs-Asian |
9.148200E-01 |
| Caucasian-vs-AfricanAmerican |
4.369200E-01 |
| Caucasian-vs-Asian |
6.625600E-01 |
| AfricanAmerican-vs-Asian |
6.980600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.317970E-01 |
| Normal-vs-Female |
5.677600E-01 |
| Male-vs-Female |
2.149800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.771600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.138830E-01 |
| Normal-vs-Age(61-80Yrs) |
1.688200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.261800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.388500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.563700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.967200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.578600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.714200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.133400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.676800E-01 |
| Classical-VS-Follicular |
7.41740000531621E-08 |
| Classical-VS-Other |
1.287020E-01 |
| Classical-VS-Normal |
4.976600E-01 |
| Tall-VS-Follicular |
1.380140E-02 |
| Tall-VS-Other |
2.800800E-01 |
| Tall-VS-Normal |
6.320200E-01 |
| Follicular-VS-Other |
8.193600E-01 |
| Follicular-VS-Normal |
3.578800E-04 |
| Other-VS-Normal |
1.276160E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.283600E-02 |
| Normal-vs-N1 |
4.710800E-01 |
| N0-vs-N1 |
3.770400E-01 |
|
|
